Chronic kidney disease - determinants of progression and cardiovascular risk. PROGREDIR cohort study: design and methods

• Published in: São Paulo medical journal 2017-03, Vol.135 (2), p.133-139
• Main Authors: Domingos, Maria Alice Muniz, Goulart, Alessandra Carvalho, Lotufo, Paulo Andrade, Benseñor, Isabela Judith Martins, Titan, Silvia Maria de Oliveira
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biomarkers; Biomarkers - urine; Brazil - epidemiology; Cardiovascular diseases; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - etiology; Cardiovascular Diseases - mortality; Cohort Studies; Disease Progression; Female; Humans; Male; MEDICINE, GENERAL & INTERNAL; Prospective Studies; Renal insufficiency, chronic; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - diagnosis; Renal Insufficiency, Chronic - mortality; Renal replacement therapy; Risk Factors
• ISSN: 1516-3180; 1806-9460; 1806-9460
• DOI: 10.1590/1516-3180.2016.0272261116

Chronic kidney disease (CKD) has become an important public health issue. The socioeconomic burden of renal replacement therapy (RRT) is very high, as is CKD-related cardiovascular mortality and morbidity. Preventive and therapeutic measures only have modest impact and more research is needed. Few cohort studies have been conducted on populations with CKD. Our aim was to establish a cohort that would include more advanced forms of CKD (stages 3 and 4). Data collection was focused on renal and cardiovascular parameters. Prospective cohort study; São Paulo, Brazil. Recruitment took place in Hospital das Clínicas, São Paulo, from March 2012 to December 2013. Data relating to medical history, food-frequency questionnaire, anthropometry, laboratory work-up, calcium score, echocardiography, carotid intimal-medial thickness, pulse-wave velocity, retinography and heart rate variability were collected. A biobank including serum, plasma, post-oral glucose tolerance test serum and plasma, urine (morning and 24-hour urine) and DNA was established. 454 participants (60% men and 50% diabetics) of mean age 68 years were enrolled. Their mean estimated glomerular filtration rate-CKD Epidemiology Collaboration was 38 ml/min/1.73 m2. Follow-up is ongoing and the main outcomes are the start of RRT, cardiovascular events and death. The PROGREDIR cohort is a promising prospective study that will allow better understanding of CKD determinants and validation of candidate biomarkers for the risks of CKD progression and mortality.